Managing lipohypertrophy in your practice
Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 3
Abstract
Lipohypertrophy (LH) is a frequent and preventable complication of insulin injection therapy and is seen in more than 50 % people with type 1diabetes. The prevalence of LH amongst type 1 diabetics in India is high. Despite increasing number of type 1 diabetes every year, the data of LH from South Asian developing countries like India is sporadic. Insulin absorption diminishes if injected at the site of LH. This increases the risk of hyperglycemia. Conversely, when the same dose of insulin is injected in the same subject at the site without LH, there is an increased risk of hypoglycemia.
Authors and Affiliations
Kavita Gupta, Sunil Gupta
Keywords
Related Articles
- EP ID EP611911
- DOI -
- Views 167
- Downloads 0
Evaluation of antihypertensive efficacy of intravenous labetalol versus oral nifedipine in preeclamptic hypertensive emergency : a randomised controlled trial.
To compare oral nifedipine with intravenous labetalol in their rapidity to control preeclamptic hypertensive emergencies. The primary outcome is number of doses required to achieve a target blood pressure of <150/100 mmH...
Adequacy of completion of radiology request forms
Radiology request forms are the sole mode of communication between the referring doctor and the radiologist in a hospital setup. Their importance, however, is highly underestimated. A radiological investigation may prove...
Future of Orthopaedics
Orthopaedic Science has become the most dynamic modality where new concepts and idea emerging day by day. We are in era of Orthopaedic Surgery where every specialty has stood like a unique specialty. Our future in develo...
Endocrinology : Scientific and societal
Endocrine disorders like diabetes, hypothyroidism and osteoporosis are widely prevalent. But these disorders very commonly remain undiagnosed and undertreated. The current issue of Journal of Indian Medical Association e...
Analysis of prevalence, risk factors & co-morbid associations between non alcoholic fatty liver disease and type 2 diabetes mellitus in a tertiary care hospital of Eastern India
Non Alcoholic Fatty Liver Disease (NAFLD) is one of the commonest causes of elevated liver enzymes in India nowadays. It is well documented that NAFLD prevalence is higher among patients with features of insulin resistan...